Patents by Inventor Maide Nur PAKSOY

Maide Nur PAKSOY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240270730
    Abstract: The invention relates to compound shown with formula I or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
    Type: Application
    Filed: February 17, 2021
    Publication date: August 15, 2024
    Inventors: Serdar DURDAGI, Muge Didem ORHAN, Timucin AVSAR, Mine YURTSEVER, Maide Nur PAKSOY, Gulsah AYDIN
  • Publication number: 20230098888
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
    Type: Application
    Filed: February 17, 2021
    Publication date: March 30, 2023
    Inventors: Mine YURTSEVER, Muge Didem ORHAN, Maide Nur PAKSOY, Gulsah AYDIN, Timucin AVSAR, Serdar DURDAGI
  • Publication number: 20230071340
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
    Type: Application
    Filed: February 17, 2021
    Publication date: March 9, 2023
    Inventors: Serdar DURDAGI, Timucin AVSAR, Muge Didem ORHAN, Maide Nur PAKSOY, Gulsah AYDIN, Mine YURTSEVER
  • Publication number: 20230073261
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
    Type: Application
    Filed: February 16, 2021
    Publication date: March 9, 2023
    Inventors: Timucin AVSAR, Serdar DURDAGI, Muge Didem ORHAN, Maide Nur PAKSOY, Gulsah AYDIN, Mine YURTSEVER
  • Publication number: 20230063449
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
    Type: Application
    Filed: February 17, 2021
    Publication date: March 2, 2023
    Inventors: Serdar DURDAGI, Timucin AVSAR, Mine YURTSEVER, Gulsah AYDIN, Maide Nur PAKSOY, Muge Didem ORHAN